Hip osteoarthritis, osteonecrosis of the femoral head, developmental dysplasia of the hip, knee osteoarthritis, etc.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. The patient has indications for primary total hip or total knee arthroplasty and has failed conservative treatment. 2. BMI <= 35. 3. Medically stable based on physical examination and medical history, able to undergo surgery and comply with postoperative follow-up. 4. The affected joint is undergoing primary total joint arthroplasty. 5. Has not participated in other clinical trials within the 12 months prior to this clinical trial.
Exclusion criteria
Exclusion criteria: 1. The subject is unable to provide written informed consent to participate in the clinical study. 2. The subject is pregnant or breastfeeding. 3. The subject is expected to undergo contralateral hip/knee arthroplasty within 12 months after the first surgery. 4. The contralateral hip/knee joint has already been enrolled in this study. 5. Other conditions that the investigator deems unsuitable for participation in this project.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Economic Status; Complication Rate;Hospitalization Costs ; Preoperative Hip Function;Postoperative Hip Function; Preoperative Knee Function;Postoperative Knee Function;X-ray;Computed tomography;Prosthesis size;Prosthesis matching rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient Demographics;Blood routine;C-reactive protein;Erythrocyte sedimentation rate;Blood biochemistry;Coagulation profile;Blood type;Preoperative eight serological tests;Operation time;Blood loss;Blood transfusion volume; | — |
Countries
Chinese
Contacts
Fourth Medical Center of the Chinese People's Liberation Army General Hospital